Amoéba
Develops natural microbiological solutions to manage bacterial and fungal risks.
ALMIB | PA
Overview
Corporate Details
- ISIN(s):
- FR0011051598 (+2 more)
- LEI:
- 9695005QNE7C8Z0LXU64
- Country:
- France
- Address:
- 38 AVENUE DES FRERES MONTGOLFIER, 69680 CHASSIEU
- Website:
- https://amoeba-nature.com/en/
- Sector:
- Manufacturing
- Industry:
- Manufacture of other chemical products
Description
Amoéba is a biotechnology company that develops natural microbiological solutions for managing bacterial and fungal risks. The company's core technology is based on the patented use of the amoeba *Willaertia magna* C2c Maky and its biocidal properties. Its primary focus is on agricultural biocontrol, offering a biofungicide derived from a mechanically lysed amoeba. This product targets plant diseases such as mildews, rusts, and powdery mildew, providing a biological alternative to chemical treatments. Amoéba has also developed applications for its technology in the treatment of bacterial risk in industrial water systems, on surfaces, and for chronic wounds.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Type / Size | Actions | |
|---|---|---|---|---|---|
| 2021-06-02 17:45 |
AMOEBA: Modalities through which the preparatory documents will be made availab…
|
English | PDF • 242.3 KB | ||
| 2021-05-10 17:35 |
AMOEBA : ASSEMBLEE GENERALE ORDINAIRE ET EXTRAORDINAIRE DU 27 MAI 2021 - MODALI…
|
French | PDF • 315.5 KB | ||
| 2021-05-10 17:35 |
AMOEBA : ORDINARY AND EXTRAORDINARY GENERAL MEETING TO BE HELD ON 27 MAY 2021 -…
|
English | PDF • 225.7 KB | ||
| 2021-05-03 17:45 |
AMOEBA : Déclaration du nombre total de droits de vote et du nombre d’actions c…
|
French | PDF • 230.1 KB | ||
| 2021-04-12 17:45 |
AMOÉBA annonce la mise à disposition du Document d’Enregistrement Universel 202…
|
French | PDF • 255.8 KB | ||
| 2021-04-12 17:45 |
AMOÉBA announces the availability of the 2020 Universal Registration Document i…
|
English | PDF • 218.0 KB | ||
| 2021-04-12 09:52 |
URD 2020
|
French | PDF • 4.1 MB | ||
| 2021-04-07 17:45 |
AMOEBA annonce l’émission de la première tranche de 60 obligations convertibles…
|
French | PDF • 334.9 KB | ||
| 2021-04-07 17:45 |
AMOEBA announces the issuance of the first tranche of 60 bonds convertible into…
|
English | PDF • 292.0 KB | ||
| 2021-04-07 08:30 |
AMOEBA : Déclaration du nombre total de droits de vote et du nombre d’actions c…
|
French | PDF • 230.0 KB | ||
| 2021-04-06 17:45 |
Amoéba soumet la demande d’autorisation de son biocide aux Etats-Unis
|
French | PDF • 281.9 KB | ||
| 2021-04-06 17:45 |
Amoéba submits its biocide application in the USA
|
English | PDF • 268.6 KB | ||
| 2021-04-06 08:30 |
Amoéba lance une nouvelle campagne massive d’essais au champ pour 2021
|
French | PDF • 269.9 KB | ||
| 2021-04-06 08:30 |
Amoéba launches a massive new field trials campaign for 2021
|
English | PDF • 194.7 KB | ||
| 2021-03-04 17:45 |
AMOEBA annonce l’émission de la douzième tranche de 26 obligations convertibles…
|
French | PDF • 347.9 KB |
Automate Your Workflow. Get a real-time feed of all Amoéba filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Amoéba
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Amoéba via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2024-08-30 | N/A | Other | Buy | 6,300 | 3,609.90 EUR |
| 2024-08-29 | N/A | Other | Sell | 5,500 | 3,564.00 EUR |
| 2024-08-28 | N/A | Other | Buy | 3,200 | 1,782.08 EUR |
| 2024-08-27 | N/A | Other | Buy | 20,049 | 11,231.45 EUR |
| 2024-08-26 | N/A | Other | Buy | 31,107 | 17,441.69 EUR |
| 2024-08-22 | N/A | Other | Buy | 2,255 | 1,298.88 EUR |
| 2024-08-20 | N/A | Other | Buy | 16,664 | 8,838.59 EUR |
| 2024-08-19 | N/A | Other | Buy | 13,390 | 6,795.43 EUR |
| 2024-08-16 | N/A | Other | Buy | 6,745 | 3,468.28 EUR |
| 2024-08-09 | N/A | Other | Buy | 40,748 | 21,559.77 EUR |
Peer Companies
